A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes

NCT07668999 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Pedis

Interventions

DRUG: ZYG24004 1% topical film-forming formulation
DRUG: ZYG24004 3% topical film-forming formulation
DRUG: Placebo topical formulation

Sponsor

Sinomune Pharmaceutical Co., Ltd